Stocks Making Significant Premarket Moves: Apogee Therapeutics Soars on Acquisition by AbbVie

Apogee Therapeutics surged over 50% premarket after announcing a $10.9 billion acquisition deal with AbbVie, while Arcosa rose more than 7% following its buyout by CRH for $8.5 billion. SpaceX shares fell more than 5%, continuing their downward trend since the IPO.

By Davis Giangiulio · CNBC ·

Stocks Making Significant Premarket Moves: Apogee Therapeutics Soars on Acquisition by AbbVie

Tickers: $ABBV $ACA $APOG $CRH $GETY $GOOGL $GPRO $MU $SPCE

Topics: Acquisition AI Partnerships Analyst Coverage Biotechnology Construction Materials Space Industry Stock Movement

Read the full article at CNBC

More World news